MedPath

Elimination of sevoflurane after conversion from inhaled to total intravenous anesthesia

Not Applicable
Recruiting
Conditions
T88.3
Malignant hyperthermia due to anaesthesia
Registration Number
DRKS00032911
Lead Sponsor
Medizinische Hochschule Hannover
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
10
Inclusion Criteria

Patients with inhalational anesthesia induction using sevoflurane followed by planned change to total intravenous anesthesia.

Exclusion Criteria

Patients with suspected or proven increased risk of malignant hyperthermia.
Patients for whom the expected duration of the operation is less than 60 minutes.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath